GENERIC VERSUS BRANDED CARBAMAZEPINE

被引：0
|
作者：
SACHDEO, RC
BELENDIUK, G
机构：
来源：
LANCET | 1987年 / 1卷 / 8547期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1432 / 1432
页数：1
相关论文
共 50 条
  • [21] Branded versus generic drug use in chronic disease management in Hong Kong
    Poon, K. H.
    HONG KONG MEDICAL JOURNAL, 2019, 25 (02) : 167 - 167
  • [22] Branded and Generic Medications - Are they Interchangeable?
    Baruch, Ruth
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2011, 15 : 11 - 12
  • [23] The effectiveness of generic versus branded advertising: The case of US dairy promotion.
    Kaiser, H
    Liu, D
    AMERICAN JOURNAL OF AGRICULTURAL ECONOMICS, 1997, 79 (05) : 1711 - 1711
  • [24] Clinical efficacy of generic versus branded latanoprost for primary open angle glaucoma
    Kim, Diana H.
    Shaffer, Lames A.
    VanderBeek, Brian L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [25] Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
    Angmo, Dewang
    Wadhwani, Meenakshi
    Velpandian, Thirumurthy
    Kotnal, Ankita
    Sihota, Ramanjit
    Dada, Tanuj
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (02) : 423 - 428
  • [26] Healthcare Costs in Renal Transplant Recipients Using Branded versus Generic Ciclosporin
    Helderman, J. Harold
    Kang, Ning
    Legorreta, Antonio P.
    Chen, Judy Y.
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2010, 8 (01) : 61 - 68
  • [27] Therapeutic efficacy of generic drugs versus branded antipsychotics and antidepressants: comparative results
    Parise, V. Fricchione
    Addeo, L.
    Laezza, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S740 - S741
  • [28] Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
    Dewang Angmo
    Meenakshi Wadhwani
    Thirumurthy Velpandian
    Ankita Kotnala
    Ramanjit Sihota
    Tanuj Dada
    International Ophthalmology, 2017, 37 : 423 - 428
  • [29] Generic Versus Branded Pharmaceutical Strategic Considerations: An Irish Focus With Global Perspective
    Daly, Kara
    DRUG INFORMATION JOURNAL, 2009, 43 (03): : 273 - 286
  • [30] Generic versus branded pharmacotherapy in Parkinson's disease: Does it matter? A review
    Go, Criscely L.
    Rosales, Raymond L.
    Schmidt, Peter
    Lyons, Kelly E.
    Pahwa, Rajesh
    Okun, Michael S.
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (05) : 308 - 312
12345